Amador Bioscience Appoints New Chief Technology Officer

PLEASANTON, Calif.: PLEASANTON, Calif., Jan. 7, 2022 /PRNewswire/ -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that Dr. Meina Liang has joined the company as Chief Technology Officer. Dr. Liang will report to Amador CEO and Chairman of the Board Dr. Bing Wang Ph.D. As...

Click to view original post